Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

This study has been completed.

First Received: September 8, 2006 Last Updated: July 31, 2007 History of Changes

Sponsor:	Danish Headache Center
Information provided by:	Danish Headache Center
ClinicalTrials.gov Identifier:	NCT00374530

Purpose

Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to known pathophysiology of headache to see if PGE2 is involved in headache pathophysiology.

Condition	Intervention
Headache Migraine	Drug: PGE2

Study Type:	Interventional
Study Design:	Randomized, Double-Blind, Placebo Control, Crossover Assignment
Official Title:	Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

Resource links provided by NLM:

Genetics Home Reference related topics: familial hemiplegic migraine

MedlinePlus related topics: Headache Migraine

Drug Information available for: Dinoprostone

U.S. FDA Resources

Further study details as provided by Danish Headache Center:

Primary Outcome Measures:

Headache

Secondary Outcome Measures:

rCBF, blood flow, diameter of STA/RA, HR, BP

Estimated Enrollment:	12
Study Start Date:	August 2006

Eligibility

Ages Eligible for Study:	18 Years to 40 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy volunteers

Exclusion Criteria:

Primary Headache, headache on the day of the investigation, hypertension, hypotension, pregnant/nursing, daily intake of medication (except oral contraceptives), Cardiovascular or CNS disease, drug/alcohol abuse, psychiatric disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00374530

Locations

Denmark
Danish Headache Center
Glostrup, Denmark, DK-2600

Sponsors and Collaborators

Danish Headache Center

Investigators

Principal Investigator:

Troels Wienecke, MD

Danish Headache Center

More Information

No publications provided

Study ID Numbers:	KA-20060026
Study First Received:	September 8, 2006
Last Updated:	July 31, 2007
ClinicalTrials.gov Identifier:	NCT00374530 History of Changes
Health Authority:	Denmark: Ethics Committee

Additional relevant MeSH terms:

Oxytocics
Physiological Effects of Drugs
Nervous System Diseases
Central Nervous System Diseases
Pain
Headache Disorders, Primary
Reproductive Control Agents
Brain Diseases

Pharmacologic Actions
Headache Disorders
Signs and Symptoms
Dinoprostone
Migraine Disorders
Therapeutic Uses
Headache
Neurologic Manifestations

ClinicalTrials.gov processed this record on February 08, 2010